<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01384149</url>
  </required_header>
  <id_info>
    <org_study_id>meirslt2011</org_study_id>
    <nct_id>NCT01384149</nct_id>
  </id_info>
  <brief_title>EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA</brief_title>
  <acronym>ETSG</acronym>
  <official_title>A Pioneer Study: External Selective Laser Trabeculoplasty for Treating Uncontrolled Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the advantages and disadvantages of external
      selective laser trabeculoplasty (SLT) in treating open angle glaucoma,compared to traditional
      SLT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      glaucoma is the 2nd leading cause for blindness in the western world.at the time
      approximately 60 million people are diagnosed as glaucoma patients with an estimated rise of
      30% in the next decade. glaucoma is defined as a progressive damage to the optic nerve
      ,followed by a damage to the visual field. high intraocular pressure (IOP) is considered a
      main risk factor.lowering IOP can be done in several ways ,including medication ,laser
      treatment and operations.

      medical treatment is effective in most cases ,but requires high daily compliance,side effects
      and availability of medication in living areas.

      laser trabeculoplasty treatment for reducing IOP is a first line treatment for patients with
      open angle glaucoma (OAG).with success rate of 70-90%, it can be done as an additive
      treatment or as a sole treatment.

      SLT or &quot;cold&quot; laser is a non-invasive treatment in which short wave lengths are being
      transduced in short intervals ,through a gonioscopic lens to the area of filtering angle.
      thec wave length is specific to cells rich in melanin (located in the filtering angle). the
      mechanism of action is regeneration of cytokine surge -causing macrophages recruitment and
      breakage of inter-cell connections at the trabecular meshwork (filtering area) and allows
      rise in fluid shift. the treatment requires several lasering to areas at the surrounding the
      wave does not cause rise in tissue heat or scaring of tissue and can be repeated.among its
      disadvantages are reduction in affect during time,causing new elevation of IOP , potential
      peripheral anterior synechia (PAS), corneal erosion or oedema,requires experience in treating
      through gonioscopic lense.

      previous reports in the literature regarding external low intensity laser (LIL)show less
      complication rate.

      our study evaluates the use of external SLT by using a standard retinal laser machine ,with
      procedure performed on the outer sclera-above the trabecular meshwork with laser parameters
      similar to those used in retinal surgeries.

      this is a prospective, randomized, comparative clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra Ocular Pressure values as a measure for treatment success</measure>
    <time_frame>6 months</time_frame>
    <description>a success is defined a decrease of &gt;/= 20% in intra ocular pressure measured after treatment -compared to intra ocular pressure measured prior to treatment a relative success in an intra ocular pressure thet is lowered post treatment in less than 20% -compared to pre-treatment. failure is considered as an intra ocular pressure equal or higher than measured prior to treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of supplementary treatment for lowering intraocular pressure</measure>
    <time_frame>6 months</time_frame>
    <description>success is defined as no need for suplemental medication for lowering intra ocular pressure ,complete failure is described as using the same amount or more of medication ,relative success in described as a need to use less hypotensive medications for lowering intraocular pressure after the procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>standart slt</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gonioscopic selective laser trabeculoplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>external slt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>perilimbal ,above trabecular meshwork 180 degrees ,100 laser dots</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>external slt</intervention_name>
    <description>Nd:YAG LASER SLT perilimbal above trabecular meshwork 180 degrees ,100 lasering dots</description>
    <arm_group_label>external slt</arm_group_label>
    <other_name>external SLT laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard slt</intervention_name>
    <description>Nd:YAG LASER SLT gonioscopic laser treatment</description>
    <arm_group_label>standart slt</arm_group_label>
    <other_name>SLT laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary Open Angle Glaucoma

          -  clinical appearance of pigment at the angle

          -  angle assessed as &gt;3 by a professional glaucoma expert

          -  IOP above target pressure under full anti-hypertensive treatment with a good
             compliance for treatment or IOP above target pressure and poor compliance to medical
             treatment due to: allergic reaction , side effects,physical inability etc.

          -  able to sign independently on an informed concent

        Exclusion Criteria:

          -  pregnancy/breast feeding

          -  glaucoma not specified as primary open angle glaucoma

          -  sensitivity to on or more of the medications in the study

          -  current /past intraocular inflammation

          -  primary open angle glaucoma with out appearance of pigment at the angle

          -  s/p laser trabeculoplasty at treatment eye

          -  inability to sign an informed concent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noa Gefen, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Meir Medical Center, Kfar Saba, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Belkin, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center, Ramat Gan ,Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ehud Asia, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center, Kfar Saba, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Audry masas-kaplan, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf Harofhe Medical Center, Beer Yaakov, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assaf Harofhe Medical Center</name>
      <address>
        <city>Beer Yaakov</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmology Department ,Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006 Mar;90(3):262-7.</citation>
    <PMID>16488940</PMID>
  </reference>
  <reference>
    <citation>The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000 Oct;130(4):429-40.</citation>
    <PMID>11024415</PMID>
  </reference>
  <reference>
    <citation>Freeman EE, Muñoz B, West SK, Jampel HD, Friedman DS. Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology. 2008 Feb;115(2):233-8. Epub 2007 Jul 26.</citation>
    <PMID>17655930</PMID>
  </reference>
  <reference>
    <citation>Worthen DM, Wickham MG. Argon laser trabeculotomy. Trans Am Acad Ophthalmol Otolaryngol. 1974 Mar-Apr;78(2):OP371-5.</citation>
    <PMID>4856873</PMID>
  </reference>
  <reference>
    <citation>Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology. 1998 Nov;105(11):2082-8; discussion 2089-90.</citation>
    <PMID>9818610</PMID>
  </reference>
  <reference>
    <citation>Alvarado JA, Katz LJ, Trivedi S, Shifera AS. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Arch Ophthalmol. 2010 Jun;128(6):731-7. doi: 10.1001/archophthalmol.2010.85.</citation>
    <PMID>20547951</PMID>
  </reference>
  <reference>
    <citation>Rachmiel R, Trope GE, Chipman ML, Gouws P, Buys YM. Laser trabeculoplasty trends with the introduction of new medical treatments and selective laser trabeculoplasty. J Glaucoma. 2006 Aug;15(4):306-9.</citation>
    <PMID>16865007</PMID>
  </reference>
  <reference>
    <citation>Coleman AL, Yu F, Evans SJ. Use of gonioscopy in medicare beneficiaries before glaucoma surgery. J Glaucoma. 2006 Dec;15(6):486-93.</citation>
    <PMID>17106360</PMID>
  </reference>
  <reference>
    <citation>Ivandic BT, Hoque NN, Ivandic T. Early diagnosis of ocular hypertension using a low-intensity laser irradiation test. Photomed Laser Surg. 2009 Aug;27(4):571-5. doi: 10.1089/pho.2008.2342.</citation>
    <PMID>19514814</PMID>
  </reference>
  <reference>
    <citation>Framme C, Walter A, Prahs P, Theisen-Kunde D, Brinkmann R. Comparison of threshold irradiances and online dosimetry for selective retina treatment (SRT) in patients treated with 200 nanoseconds and 1.7 microseconds laser pulses. Lasers Surg Med. 2008 Nov;40(9):616-24. doi: 10.1002/lsm.20685.</citation>
    <PMID>18951425</PMID>
  </reference>
  <reference>
    <citation>Klatt C, Saeger M, Oppermann T, Pörksen E, Treumer F, Hillenkamp J, Fritzer E, Brinkmann R, Birngruber R, Roider J. Selective retina therapy for acute central serous chorioretinopathy. Br J Ophthalmol. 2011 Jan;95(1):83-8. doi: 10.1136/bjo.2009.178327. Epub 2010 Jun 15.</citation>
    <PMID>20554506</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2011</study_first_posted>
  <last_update_submitted>August 11, 2014</last_update_submitted>
  <last_update_submitted_qc>August 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intra ocular pressure</keyword>
  <keyword>open angle glaucoma</keyword>
  <keyword>selective laser trabeculoplasty</keyword>
  <keyword>external laser treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

